Markets
AbCellera Biologics Stock Analysis: Momentum vs. Fundamentals in 2026
AbCellera Biologics sits at a compelling inflection point in August 2026, with technical momentum building against a backdrop of unresolved fundamental questions about royalty revenue and pipeline depth. Here is what traders and investors need to know right now.